Skip to content
GERICLINICS

GeriQBank · Paper III · Q1

Etiopathogenesis, clinical manifestations, diagnostic algorithm and management of malabsorption

High YieldAsked ×27-mark note
Chapter
Gastroenterology & Nutrition
Years asked
Not recorded in the source
Frequency
Set 2× in Paper III (2009–2025)

As set in the university paper

  • Malabsorption / malabsorption syndrome in the elderly.

    Paper III · Gastroenterology & Nutrition · asked ×2 · 7-mark note · see in paper list

Answer framework

  1. Definition and ageing physiology — global versus selective; maldigestion versus malabsorption; healthy ageing does not cause it; selective vitamin changes; preserved motility
  2. Etiopathogenesis — luminal, mucosal, post-mucosal, stasis with bacterial overgrowth; post-surgical causes; Indian causes
  3. Clinical manifestations — the classical picture; the atypical geriatric picture; deficiency clues
  4. Diagnostic algorithm — screening bloods; confirming fat malabsorption; localising the defect (coeliac, pancreatic, SIBO); imaging; excluding malignancy
  5. Management — treat the cause; SIBO antibiotics; correct deficiencies; nutritional rehabilitation; symptomatic measures and PPI deprescribing
  6. Recent updates — UEG 2025, ACG coeliac guideline, ESsCD no-biopsy pathway, coeliac disease in older people, exocrine pancreatic insufficiency

An exam answer plan drawn from the detailed answer below. Use it to attempt the question first.

Detailed answer

Pro · free in beta
Attempt it firstOutline your answer as a 7-mark note before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer

Short revision answer

  • Malabsorption is defective uptake of digested nutrients (global or selective); maldigestion is failure of luminal breakdown (pancreatic or bile salt). Healthy ageing does not cause malabsorption — in an older person it always signals disease. Vitamin D absorption falls with age, and B12 absorption falls when there is hypochlorhydria.
  • Mechanisms: luminal (pancreatic insufficiency, bile salt deficiency, hypochlorhydria from atrophic gastritis or PPIs); mucosal (coeliac disease, tropical sprue, Crohn's, giardiasis, drugs such as olmesartan, amyloidosis, radiation); post-mucosal (lymphangiectasia, lymphoma, mesenteric ischaemia, right heart failure).
  • Bacterial overgrowth is rare in healthy older people but common with stasis — diabetic autonomic neuropathy, small-bowel diverticula, hypochlorhydria — and after gastrectomy, blind loops or resection. In India add tropical sprue, intestinal TB, giardiasis, strongyloidiasis and HIV.
  • The classic picture is diarrhoea, steatorrhoea, weight loss and bloating, but older patients are often oligosymptomatic — weight loss, anaemia, fatigue or osteomalacia without diarrhoea. Deficiency clues: anaemia, osteomalacia, bruising, glossitis, night blindness, oedema, neuropathy.
  • Step 1: CBC with MCV, iron, B12, folate, calcium, phosphate, albumin, INR (correcting with vitamin K), 25(OH)D and TSH. Step 2: confirm fat malabsorption (Sudan III stain, or 72-hour faecal fat >7 g/day); faecal calprotectin for inflammation.
  • Step 3, localise the defect: IgA anti-tTG with total IgA, then endoscopy with 4–6 duodenal biopsies; faecal elastase-1 (<200 µg/g suggests and <100 µg/g indicates severe pancreatic insufficiency) with CT/MRCP; duodenal aspirate culture or a breath test for overgrowth. D-xylose absorption is abnormal in mucosal disease but normal in pancreatic disease.
  • Step 4: CT enterography, capsule endoscopy or CT angiography as needed — and always exclude malignancy first in older patients (low threshold for colonoscopy and imaging).
  • Treat the cause: gluten-free diet, pancreatic enzymes, tetracycline and folate for tropical sprue, ATT for TB; for overgrowth, metronidazole, tetracycline, quinolones or rifaximin for one to four weeks (cyclically if recurrent). Correct deficiencies (parenteral iron if needed, B12, folate, calcium and vitamin D, vitamin K).
  • Nutrition: a high-energy, high-protein diet, supplements, MCT oil, lactose restriction if needed, dietitian input, and watch for refeeding syndrome. Loperamide and clonidine carry significant adverse effects in older people. Deprescribe PPIs that are no longer indicated.
  • Updates: UEG 2025 recommends a structured stepwise work-up; ACG 2023 keeps duodenal biopsy as the coeliac standard; ESsCD 2025 allows no-biopsy diagnosis only under 45, so older adults still need biopsy; coeliac disease is increasingly diagnosed after 65; exocrine pancreatic insufficiency affects about 10% of older people.

Condensed by GeriClinics from the detailed answer below, with no new facts added.

1.

Etiopathogenesis, clinical manifestations, diagnostic algorithm and management of malabsorption

15 MARKS RECURRING TOPIC

Definition and Ageing Physiology

1.

Malabsorption means defective passage of digested nutrients into the blood and lymph. It may be global (all nutrients) or selective (one nutrient, e.g. B12).

2.

Distinguish maldigestion (failure of luminal breakdown — pancreatic or bile salt problem) from malabsorption (failure of mucosal uptake or lymphatic transport).

3.

Healthy ageing alone does not cause malabsorption. Pathy's states that although brush-border enzymes fall, digestion and absorption of carbohydrate, fat and protein remain normal in healthy old age.

4.

Age-related changes are selective: vitamin A absorption increases, vitamin D absorption decreases, folate absorption falls slightly, and B12 absorption falls when hypochlorhydria is present.

5.

Small-intestinal motility and transit are essentially preserved with healthy ageing; therefore bacterial overgrowth is rare in the healthy elderly. When it occurs, look for disease, not for age.

Etiopathogenesis — Four Mechanisms

6.

Luminal (maldigestion): pancreatic exocrine insufficiency (chronic pancreatitis, pancreatic cancer), bile salt deficiency (cholestasis, ileal resection), and hypochlorhydria from atrophic gastritis or long-term PPI use.

7.

Mucosal: coeliac disease, tropical sprue, Crohn's disease, giardiasis, drug-induced enteropathy (olmesartan, NSAIDs, colchicine), amyloidosis, radiation enteritis.

8.

Post-mucosal (lymphatic/vascular): intestinal lymphangiectasia, lymphoma, chronic mesenteric ischaemia, constrictive pericarditis, right heart failure.

9.

Stasis with bacterial overgrowth (SIBO): Pathy's identifies the classic geriatric mechanism — diabetes with autonomic neuropathy, small-intestinal diverticula, and reduced gastric acid cause stasis and predispose to overgrowth, causing malnutrition and diarrhoea.

10.

Post-surgical causes matter in the elderly: previous gastrectomy, blind loop, ileal resection, and short bowel after mesenteric ischaemia.

11.

In India, always add tropical sprue, intestinal tuberculosis, giardiasis, strongyloidiasis, and HIV enteropathy to the differential — these are far commoner than in Western series.

Clinical Manifestations

12.

Classical picture — chronic diarrhoea, steatorrhoea (bulky, pale, offensive, floating stool), weight loss, abdominal bloating and flatulence.

13.

Geriatric picture is atypical and oligosymptomatic: presentation is often only unexplained weight loss, anaemia, fatigue or a metabolic bone disease, with little or no diarrhoea. Diarrhoea may even be absent.

14.

Deficiency-based clues: iron/folate/B12 deficiency anaemia; osteomalacia and proximal myopathy (vitamin D, calcium); bruising (vitamin K); glossitis and cheilitis (B-complex); night blindness (vitamin A); oedema (hypoalbuminaemia); peripheral neuropathy (B12).

15.

Fat-soluble vitamin loss (A, D, E, K) occurs in maldigestion and steatorrhoea, whereas isolated B12 loss suggests ileal or gastric pathology.

Diagnostic Algorithm

16.

Step 1 — Confirm malabsorption and screen: CBC with MCV, iron studies, B12, folate, calcium, phosphate, albumin, prothrombin time, 25(OH)D, TSH. A raised INR that corrects with vitamin K is a useful bedside pointer.

17.

Step 2 — Confirm fat malabsorption: qualitative Sudan III stain of stool (simple, available in India) or 72-hour faecal fat (>7 g/day). Faecal calprotectin distinguishes inflammatory from non-inflammatory causes.

18.

Step 3 — Localise the defect: Mucosal → IgA anti-tTG plus total IgA, then upper GI endoscopy with 4–6 duodenal biopsies (including bulb). Pancreatic → faecal elastase-1; <200 µg/g suggests, <100 µg/g indicates severe exocrine insufficiency; CT/MRCP for structural disease. SIBO → Pathy's: culture of duodenal aspirate or glucose/xylose hydrogen breath test; sensitivity and specificity vary widely, so a negative test after antibiotics increases diagnostic certainty.

19.

Step 4 — Imaging and exclusion of malignancy: CT enterography, capsule endoscopy or enteroscopy for obscure cases; CT angiography if chronic mesenteric ischaemia is suspected (post-prandial pain, food fear, weight loss).

20.

Always exclude malignancy first in the elderly. Weight loss plus altered bowel habit in an older patient requires a low threshold for colonoscopy and cross-sectional imaging before labelling anything "functional".

Management

21.

Treat the cause: lifelong gluten-free diet for coeliac disease; pancreatic enzyme replacement for exocrine insufficiency; tetracycline plus folic acid for tropical sprue; ATT for intestinal tuberculosis.

22.

SIBO (Pathy's): metronidazole, tetracycline or quinolones, or non-absorbed rifaximin, given for one to four weeks, repeated cyclically if recurrent — noting that Pathy's stresses there is a paucity of controlled data to guide practice.

23.

Correct deficiencies aggressively: parenteral iron if oral is not absorbed, B12 (oral high-dose or IM), folate, calcium with vitamin D, and vitamin K where INR is prolonged.

24.

Nutritional rehabilitation: high-energy, high-protein diet; oral nutritional supplements; MCT oil for severe steatorrhoea; lactose restriction if secondary lactase deficiency; involve a dietitian, and monitor for refeeding syndrome in the very depleted.

25.

Symptomatic and stewardship measures: Pathy's notes loperamide and clonidine may help when no cause is found, but warns older patients are especially prone to adverse effects — constipation, urinary retention and glaucoma with loperamide; hypotension, bradycardia, sedation and dry mouth with clonidine. Deprescribe the PPI if the indication has lapsed, since acid suppression drives both B12 deficiency and overgrowth.

Latest Updates (2023–Present)

UEG 2025 guideline on malabsorption in adults gives the first unified framework — history and drug review first, then targeted functional and endoscopic testing rather than a scattergun panel. It highlights that in autoimmune atrophic gastritis, parietal cell loss, SIBO and iatrogenic hypochlorhydria from chronic PPI use all aggravate B12 deficit, and that B12 screening in the elderly matters because some neurological abnormalities reverse with supplementation (United European Gastroenterol J, 2025).

ACG guideline update on coeliac disease (2023) retains EGD with multiple duodenal biopsies as the confirmatory standard in adults, recommends case-finding rather than mass screening, and requires serology and biopsy to be done on a gluten-containing diet (Am J Gastroenterol, 2023).

ESsCD 2025 guidelines conditionally permit a no-biopsy diagnostic pathway only in adults under 45 years with markedly raised IgA anti-tTG — meaning older adults still require duodenal biopsy, an important exam-relevant caveat (United European Gastroenterol J, 2025).

Coeliac disease in the elderly is increasingly recognised: a UK cohort found the proportion of coeliac diagnoses made over age 65 rose from 0% in 1990–91 to 18.7% by 2016–17, with older patients presenting less often with diarrhoea and more often with B12 deficiency (UK coeliac cohort study, 2020).

Population data support routinely considering exocrine pancreatic insufficiency as a cause of unexplained diarrhoea and bloating in older adults, with reported prevalence around 10% by faecal elastase-1 in the elderly (Norwegian population data cited in current EPI literature).

Current Practice Update

Textbook position (Pathy's / Essentials) Current evidence (2023–2026)

SIBO diagnosed by duodenal aspirate culture or Same tests remain, but UEG 2025 emphasises a structured stepwise hydrogen breath test; both with variable accuracy. work-up with drug history first and warns against over-testing; PPI use is now formally listed as an aggravating cause.

Coeliac disease considered largely a younger-adult Now recognised as a growing elderly diagnosis, presenting with disease. anaemia and B12 deficiency rather than diarrhoea; the no-biopsy pathway is restricted to under-45s, so biopsy remains mandatory in geriatric practice.

Little dedicated emphasis on pancreatic exocrine Faecal elastase-1 is now the routine first-line non-invasive test; <200 insufficiency as a geriatric cause. µg/g suggests and <100 µg/g indicates severe insufficiency. Antibiotic courses for SIBO based on limited controlled Position unchanged — rifaximin and cyclical courses remain data. empirical; high-quality RCT evidence in older adults is still awaited.

Examiner's Tip — mark-earning lines

"Ageing itself does not cause malabsorption — Pathy's states digestion and absorption of fat, carbohydrate and protein remain normal in healthy old age; malabsorption in an older patient always signals underlying pathology." "In the elderly the presentation is oligosymptomatic — unexplained weight loss, anaemia or osteomalacia without diarrhoea."

"Bacterial overgrowth is rare in the healthy elderly but common where there is stasis — diabetes, small-bowel diverticula and hypochlorhydria."

"Exclude malignancy before diagnosing benign malabsorption in any patient over 65."

Extra Points to Remember (recurring topic)

D-xylose test: abnormal in mucosal disease, normal in pure pancreatic disease — a classic viva discriminator. MMA and homocysteine: both raised in B12 deficiency; only homocysteine raised in folate deficiency. Drug-induced enteropathy to name: olmesartan (sprue-like), NSAIDs, colchicine, metformin (B12), methotrexate (folate). Whipple's disease — rare but examinable: PAS-positive macrophages, treated with ceftriaxone then long-course co-trimoxazole.

Steatorrhoea threshold to quote: faecal fat >7 g/day on a 100 g fat diet.

How was your recall?

Rating marks the question complete. “Need another pass” also adds it to your bookmarks.

References

Spotted an error or something out of date?Report a problem with this page